Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: IN VITRO STRATEGIES LIMITED LIABILITY COMPANY
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-23 to 2024-09-29
Current total value of award: $140750
Description: BIOACTIVITY ASSAY DEVELOPMENT CONSULTANT SUPPORT SERVICES